Pharma's Almanac

Pharma's Almanac The online answer to the quarterly publication,, is designed to be a platform that inspires opinion, ideas and collaboration.

Pharma's Almanac now offers weekly trends and insights! Sign up for our weekly newsletter here: https://www.pharmasalman...
Sign Up For Newsletter

Pharma's Almanac now offers weekly trends and insights! Sign up for our weekly newsletter here:

NICE INSIGHT / THAT’S NICE 89 Fifth Avenue Fifth Floor New York, NY  10003-3020+1 212 366 4455 New York Raleigh Philadelphia Chicago San Diego Santa Monica San Francisco London Frankfurt Düsseldorf  Shanghai

Pharma's Almanac | IssueQ12017

Over 300 articles now posted on! Check out our latest edition on Big Data.

IssueQ12017 | Pharma's Almanac

Pharma's Almanac: Nice Insight's Content Community

Pharma's Almanac online now contains more than 200 articles! Join today. Membership is completely free!

A new trend in lab automation is to fully automate drug-discovery workflows through “robotic researchers” that apply advanced machine learning & artificial intelligence.


New York, NY


(212) 366-4455


Be the first to know and let us send you an email when Pharma's Almanac posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Nearby media companies

Other Media/News Companies in New York

Show All


Mark Butler, President and Managing Director of the Americas, talks with Nigel Walker from Pharma's Almanac about new technologies and meeting our clients’ needs for flexibility and accelerated timelines with our Inceptioneering program. Read how we can get your project started on the right track before you put pen to paper here #CDMO #Innovation #CellTherapy #GeneTherapy
IPS’ headquarters is located in Cellicon Valley, the globally recognized hub of cell & gene therapy research, talent, and companies. Backed by a local pool of expertise, we deliver the R&D facilities you need to improve and save lives. Read more of Ana Collins’ thoughts on Philadelphia’s growing reputation. #CDMO #Innovation #CellTherapy #GeneTherapy Pharma's Almanac
3D organoid models derived from human tissue are utilized for drug discovery and screening because of their ability to predict clinical human outcomes. They offer incredible potential for the future of personalized medicine. However, to realize this, these models must be able to operate in a high-throughput environment for capacity, efficiency, and practical utility. Read more in this new insightful Pharma's Almanac piece:
Check out Pharma's Almanac Editor in Chief David Alvaro, Ph.D., BioVectra Inc. Scott Doncaster, Neil Morrison, and Cameron Graham's discussion about the company’s addition of #abec single-use fermenter technology. Read more: #manufacturing #pharma #abec
In projects that require people from all over the world, there are bound to be disagreements. Sandra Bones and Gareth Davies share the 10 strategies we took to create a culture of empowerment, collaboration, and respect among all team members to reach a compromise and provide the best solution for our client, Bavarian Nordic. Read the full article at*****on. #TeamBuilding #UBUNTU #ProjectLeadership #AEC #Collaboration #PharmasAlmanac Pharma's Almanac
When asked his thoughts on the most significant pharmaceutical industry trend in 2021, Senior Process Consultant, Luis Martinez states that there will be a boost in AI digital systems. “A clear tendency towards digitalized systems has been in constant development and has a strong impact on the pharmaceutical industry’s present and future development.” Read Luis’ full response in the Pharma's Almanac Roundtable article. #ArtificialIntelligence #AI #Pharmaceutical #Pharma
COVID-19 forced companies to rethink traditional marketing and business development strategies. As a professional services firm, we rely heavily on communication and collaboration for our projects. Read the latest Pharma's Almanac's Roundtable for thoughts from Head of Global Marketing and Communications, Ana Collins, about our virtual take on connecting. #COVID19 #BusinessDevelopment #Pandemic #Marketing
Personalized medicine is disrupting changing the life sciences industry frame of work, but it can be expensive difficult to build retrofit the manufacturing facilities for these treatments. Our iCON ex*****on model helps our clients overcome this obstacle. Watch Brian Peasley’s interview to learn how we can prep for these projects off-site and save our clients time and money. #PersonalizedMedicine #iCON #Pharma #LifeSciences Pharma's Almanac
Thanks Pharma's Almanac for supporting the Yale University Innovation Summit 2020. Please join us on May 13th for a day of innovation and networking. Link to register and other Summit details are within the article. #pharma #innovation #innovationsummit #YaleInnovationSummit #lifesciences
Dopo l’acquisizione della canadese ImportFab, la storia di Labomar inizia a girare per il mondo. Oggi sulle pagine di Pharma's Almanac, rivista americana che dedica approfondimenti ai nuovi trend del settore farmaceutico, biotecnologico, accademico, potete leggere il contributo-intervista al nostro AD Walter Bertin. With the recent acquisition of Canadian CMO ImportFab, Labomar fame has started to tour the world. Today it’s on the page of Pharma's Almanac, a go-to resource for industry happenings, from in-depth analysis of pharma/biotech research and discovery to manufacturing, the supply chain and future tech.
This article is the first of a two-part article written for Pharma's Almanac discussing the unique value proposition of pharmaceutical manufacturing equipment. All manufacturing organizations need to responsibly manage assets, but pharmaceutical equipment requires unique strategies to manage and recapture the value of equipment.
From our COO, Matt Hicks: Pharma's Almanac: With Expertise Comes Security: Protect your facility and assets by using a trusted expert to remove surplus equipment.